Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model

European Journal of Pharmacology

Volumn 556, Issue 1-3, 2007, Pages 115-120

  du Toit, Eugene F ^a   Genade, Sonia ^a   Carlini, Sophia ^a   Moolman, Johan A ^a   Brunner, Friedrich ^b   Lochner, Amanda ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

eNOS overexpression; Ischaemia reperfusion injury; Myocardium; Preconditioning

Indexed keywords

NITRIC OXIDE SYNTHASE;

ANIMAL TISSUE; ARTICLE; CONDITIONING; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART; HEART AFTERLOAD; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART PRELOAD; HEART WORK; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION; SYSTOLIC BLOOD PRESSURE; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; CYCLIC AMP; CYCLIC GMP; FEMALE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; SEX FACTORS;

EID: 33846116630     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.11.004     Document Type: Article

References (23)

1. Bae S., and Zang L. Gender differences in cardioprotection against ischaemia/reperfusion injury in adult rat hearts: focus on Akt and protein kinase C signalling. J. Pharmacol. Exp. Ther. 315 (2005) 1125-1135
2. Bell R.M., and Yellon D.M. The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: lowering of the preconditioning threshold. An investigation in eNOS knockout mouse. Cardiovasc. Res. 52 (2001) 274-280
3. Brunner F., Maier R., Andrew P., Wolkart G., Zechner R., and Mayer B. Attenuation of myocardial ischaemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Cardiovasc. Res. 57 (2003) 55-62
4. Depré C., Fiérain L., and Hue L. Activation of nitric oxide synthase by ischaemia in the perfused heart. Cardiovasc. Res. 33 (1997) 82-87
5. Du Toit E.F., Miyashiro J., McCarthy J., Opie L.H., and Brunner F. Effects of nitrovasodilators and inhibitors of nitric-oxide synthase on ischaemic and reperfusion functions in rat isolated hearts. Br. J. Pharmacol. 123 (1998) 1159-1167
6. Du Toit E.F., Meiring J., and Opie L.H. Relation of tissue cyclic nucleotide ratios to ischaemic/reperfusion injury in the nitric oxide donor treated rat heart. J. Cardiovasc. Pharmacol. 38 (2001) 529-538
7. Glick B., Nguyen Q., and Broderick T.L. Depression in mechanical function following ischaemia in the female rat heart: role of fatty acids and altered mitochondrial respiration. J. Gend.-Specif. Med. 6 (2003) 22-26
8. 2+ current in adult rabbit atrioventricular nodal cells. Circ. Res. 78 (1996) 998-1008
9. Jones S.P., and Bolli R. The obiquitous role of nitric oxide in cardioprotection. J. Mol. Cell. Cardiol. 40 (2006) 16-23
10. Jones S.P., Greer J.J.M., Kakkar A.K., Ware P.D., Turnage R.H., Hicks M., van Haperen R., de Crom R., Kawashima S., Yokoyama M., and Lefer D. Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury. Am. J. Physiol. 286 (2004) H276-H282
11. Lefer A.M., Siegfried M.R., and Ma X.L. Protection of ischemia-reperfusion injury by sydnonimine NO donors via inhibition of neutrophil-endothelium interaction. J. Cardiovasc. Pharmacol. 22 Suppl 7 (1993) S27-S33
12. Li Y., and Kloner RA. Is there a gender difference in infarct size and arrhythmias following experimental coronary occlusion and reperfusion?. Thromb. Thrombolysis 2 (1995) 21-25
13. Lochner A., Marais E., Genade S., and Moolman J. Nitric oxide: a trigger for classic preconditioning?. Am. J. Physiol. 279 (2000) H2752-H2765
14. Lochner A., Marais E., Du Toit E.F., and Moolman J. Nitric oxide trigger classic ischaemic preconditioning. Ann. N.Y. Acad. Sci. 962 (2002) 402-414
15. Lochner A., Genade S., and Moolman J.A. Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery. Basic Res. Cardiol. 98 (2003) 337-346
16. Massion P.B., Dessy C., Desjardins F., Pelat M., Havaux X., Belge C., Moulin P., Guiot Y., Feron O., Janssens S., and Balligand J.L. Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction. Circulation 110 (2004) 2666-2672
17. Mongillo M., Tocchetti C.G., Terrin A., Lassandron V., Cheung Y.F., Dostmann W.R., Pozzan T., Kass D.A., Paolocci N., Houslay M.D., and Zaccolo M. Compartmentalized phosphodiesterase-2 activity blunts β-adrenergic cardiac inotropy via an NO-cGMP dependent pathway. Circ. Res. 98 (2005) 226-234
18. Opie L.H. Role of calcium and other ions in reperfusion injury. Cardiovasc. Drugs Ther. 5 (1991) 237-247
19. Przyklenk K., Ovize M., Bauer B., and Kloner R.A. Gender does not influence acute myocardial infarction in adult dogs. Am. Heart J. 129 (1995) 1108-1113
20. Schulz R., Kelm M., and Heusch G. Nitric-oxide in myocardial ischaemia/reperfusion. Cradiovasc. Res. 61 (2004) 402-413
21. Siegfried M.R., Carey C., Ma X.L., and Lefer A.M. Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion. Am. J. Physiol. 263 (1992) H771-H777
22. Wang M., Baker L., Tsai B.M., Meldrum K.K., and Meldrum D.R. Sex differences in the myocardial inflammatory response to ischaemia-reperfusion injury. Am. J. Physiol. 288 (2005) E321-E326
23. Willems L., Zatta A., Holmgren K., Ashton K.J., and Haedrick J.P. Age-related changes in ischaemic tolerance in male and female mouse hearts. J. Mol. Cell. Cardiol. 38 (2005) 241-244